Long School of Medicine

Groundbreaking research offers hope to unlock the keys to childhood type 2 diabetes

February 16, 2022

Yidong Bai, PhD, professor, Department of Cell Systems and Anatomy, was recently awarded a $1.2 million grant from the Baptist Health Foundation of San Antonio, whose mission is focused on improving community health. The funds will be used to investigate the role of mitochondrial regulation and dysfunction in childhood type 2 diabetes, which is particularly […]

Congratulations to the 2022 Presidential Awards recipients

February 15, 2022

Every day, our employees work tirelessly to advance our missions of education, research, clinical care and community service. Established in 1985, the Presidential Excellence Awards recognize exemplary performance by individuals who consistently excel in their positions and demonstrate a strong commitment to the mission and core values of UT Health San Antonio.

John Calhoon, MD, UT Health San Antonio professor and cardiothoracic surgeon in the Department of Cardiothoracic Surgery

Dr. John H. Calhoon elected President of the Society of Thoracic Surgeons

February 4, 2022

John H. Calhoon, MD, professor and chair of the President’s Council for Excellence in Surgery at UT Health San Antonio, was elected President of the Society of Thoracic Surgeons (STS) during the organization’s annual meeting on Jan. 30, 2022.

Trailblazing diabetes researcher receives 2022 Luminary in Cardiometabolic Medicine Award

January 28, 2022

Noted diabetes researcher Ralph DeFronzo, MD, has received the 2022 Luminary in Cardiometabolic Medicine award from the Metabolic Institute of America. Dr. DeFronzo is chief of diabetes at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and deputy director of the University Health System’s Texas Diabetes Institute. As the […]

Photo of Band-Aid on arm of vaccinated person.

Can HIV infection be prevented? First mRNA vaccine study for HIV in San Antonio’s history is getting underway.

January 27, 2022

UT Health San Antonio and clinical partner University Health soon will begin a Phase 1 clinical research study of an HIV vaccine candidate produced by Moderna.

Photo of baby with cancer

Team IDs mechanism underlying rare children’s blood cancer

January 24, 2022

Researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), reporting this week in the journal Proceedings of the National Academy of Sciences, identified a mechanism through which two antiviral genes, when mutated, promote a childhood cancer called pediatric myelodysplastic syndrome (MDS). Scientists at Oklahoma State University and Cornell University collaborated […]